Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. - Wikidata - awgldk - TriplyDB

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

http://www.wikidata.org/entity/Q34102992

about

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment Targeting tumor-associated macrophages to combat pancreatic cancer Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin Macrophage plasticity and polarization: in vivo veritas Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.Tumor associated macrophages and neutrophils in tumor progression.Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.Advances in the targeted therapy of liposarcoma.Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer Pathogen recognition by the long pentraxin PTX3.Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.Solid tumor differentiation therapy - is it possible?Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.The immune network in thyroid cancer Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma.Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3.Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Liposarcoma: molecular genetics and therapeutics.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.Cancer-promoting tumor-associated macrophages: new vistas and open questions.Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.

P2860

Q26745502-3F1DDDD1-167A-4901-B75D-9E5D7692AE78 Q26851658-AA658162-0B4A-4333-9646-C8E85D708424 Q28076103-8638792E-9C88-4F42-B138-EAEF6C793B94 Q28087771-171F1129-0649-4B8E-8F43-324327F8889D Q29547620-4B177120-F086-470F-8768-708F0A50974D Q33428382-E27BE746-F4F9-4AF9-B3A7-518A3366F7FA Q33442984-884C3DE4-77F4-4413-954F-28B21547081F Q33617922-98F3A097-D9B0-460E-A03A-CBC0D56501EE Q33632041-0EE334DF-7BCD-4832-889C-493282C854D2 Q33632047-9DE99555-2063-4DB2-AD32-8E5139BC1574 Q33649056-3AC8EA35-D11B-4F8E-95FD-6ACE7843266C Q33921802-D8A6CD3F-110F-4D9F-B5DE-B8B9C33CE066 Q34306107-9A9A306A-79DE-44EF-B1A2-7CD252D9B194 Q34650482-DD99B39F-5310-4770-BDF5-75EBAEAEC908 Q34736667-8BCE9192-65CD-4787-AA21-05295196DCCB Q34898364-81E1ECBF-46CF-4B4D-A57A-13BFB14920D9 Q34952133-354952C7-B402-4931-AD11-EA77D3842896 Q34996149-92B36473-141B-4E7E-A1F3-0B7C2450E2F5 Q35054493-596EA698-4250-4743-8C33-A0AECBE2E265 Q35131481-D8E26E49-6416-4997-AA71-24B2ED0822D6 Q35246995-1BFF943B-C85E-4777-B3D0-5DC8C2AA9068 Q35582297-502B747B-310D-422C-9BB6-BB7AF263DCD4 Q35898258-C7B7944C-2D3C-46EA-8923-873020814A98 Q35918276-47C1C736-7E3A-4BF2-8B9D-BD058F7E843E Q36071880-949C1F8A-3733-46DC-8E34-EADC02E73B69 Q36414357-16414E6D-104C-475B-9351-7CA528BBA98C Q37079138-B1A7C961-5A4B-42D3-BA92-32CD8CFC856F Q37081859-51E7779C-2B7B-464E-A5BB-D6C0C81AF192 Q37148134-E3890B99-5439-4C5A-AC7E-DA958F3443E2 Q37214309-FAFE8796-ECB3-4489-8CA9-20423EA63529 Q37350801-E5AA213D-CC79-4324-A2DD-617E1C13BDA1 Q37660315-840A2C2F-E7DD-4849-903F-A8E483FF5FCA Q37688261-321BA29A-CD63-4D91-BB1E-E7F7155A3DA9 Q37829504-7FADDE43-703B-4F03-ADBF-9927C8F4205A Q37831160-3B0292DD-406C-4BE6-9E75-CB1E922381B6 Q37901025-830A6C91-54FA-4466-B0F3-5C9F86253B05 Q37930487-6B30BD18-722D-4DF8-844E-402394B35B64 Q37939626-74AB8ADB-7CC3-40A8-9942-F6A8607939CA Q37945300-71B1582D-0300-43E9-A2F1-C518EA2CFCE6 Q37974937-F0E10CD4-EFEA-48D9-85FC-D4BCF04B634D

P2860

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

http://www.wikidata.org/entity/Q34102992

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@ast

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@en

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@nl

type

label

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@ast

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@en

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@nl

prefLabel

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@ast

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@en

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

@nl

P1433

Q34102992-88316C94-9861-494D-B557-EAE1E21181BD

P1476

Q34102992-AF2A19BF-4761-4F50-A6DC-4AA3D9D9BE6C

P2093

Q34102992-008E6EEE-92A5-4110-9DF7-92887AABFF65

Q34102992-038DD26A-D564-4B09-B0A9-3ABCE4F66B13

Q34102992-18775B87-82DB-41DF-B234-A50D7DCABD33

Q34102992-4CE145D4-D926-4A90-A187-31A4A3384758

Q34102992-5AC7FB78-8245-40A9-AF89-4A1633F0FBA9

Q34102992-82DA08ED-C071-429A-991D-DFF2885D15F4

Q34102992-85ED5B74-AE24-49CC-932F-A9A7635A1B67

Q34102992-89435C23-8D5F-41BD-A42A-3677934201A8

Q34102992-90FDE006-8F4A-4592-B76F-258709504FC0

Q34102992-A0C71243-6596-464A-9F97-E2A0CE60385E

P304

Q34102992-7CC47CB0-402B-471A-8A7B-214C1E9AE68A

P31

Q34102992-76259A1E-42F1-4D6C-9731-52ADE9220910

P356

Q34102992-3BF854DE-5DCA-427C-8A9F-2A0ED1B82A8E

P407

Q34102992-316B7537-EBC2-4E6E-A1DB-F760049FF85C

P433

Q34102992-2DA31146-0FAF-4ED8-B412-0F1F5D0A9848

P478

Q34102992-083C1EE0-31CD-42E8-990A-C99797595539

P50

Q34102992-15EBCF66-0E65-4059-8B6C-97113836A0C6

Q34102992-18385C8F-C35A-4AAB-A413-78C6CCE40F5F

Q34102992-1CFF9260-AF60-4589-95EA-7A7B69893927

Q34102992-4018944F-C598-4948-961F-115106A634A8

Q34102992-43DC76C4-C07F-4A11-AF2A-F4C6D46E0DF8

Q34102992-816A5990-6124-49A0-8B2A-3427634CB123

Q34102992-A56BF6E9-9762-47A0-A1C1-85D9A66DC7B3

Q34102992-F8954888-928C-44FE-A4A5-9650AD1AA0DF

P577

Q34102992-B4D4FFEC-F757-4BBC-B45C-966BD4387FB3

P698

Q34102992-63BE41D6-C0B8-44DB-BF3D-193B09B56E40

P356

0008-5472.CAN-09-2335

P1433

Cancer Research

P1476

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells

@en

P2093

Carlos Maria Galmarini

http://www.w3.org/2001/XMLSchema#string

Emanuela Virdis

http://www.w3.org/2001/XMLSchema#string

Eugenio Erba

http://www.w3.org/2001/XMLSchema#string

Eva Tarantino

http://www.w3.org/2001/XMLSchema#string

Fabio Pasqualini

http://www.w3.org/2001/XMLSchema#string

Federica Grosso

http://www.w3.org/2001/XMLSchema#string

Giovanni Germano

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Tercero

http://www.w3.org/2001/XMLSchema#string

Matteo Simone

http://www.w3.org/2001/XMLSchema#string

Michele Tavecchio

http://www.w3.org/2001/XMLSchema#string

P304

2235-2244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-2335

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Mantovani

Alessandro Gronchi

Paolo Giovanni Casali

Maurizio D'Incalci

Roberta Sanfilippo

Manuela Nebuloni

P577

2010-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20215499

http://www.w3.org/2001/XMLSchema#string